BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  MabVax Therapeutics Announces Completion of Enrollment and Dosing in Initial Cohort of MVT-1075 Radioimmunotherapy Phase I Trial for the Treatment of Pancreatic, Colon and Lung Cancers

  This Phase 1 first-in-human clinical trial is an open-label, multi-center study evaluating the safety and efficacy of MVT-1075 in approximately 22 patients with CA19-9 positive malignancies in the U.S.

  December 13, 2017

   · 

  6 min read
• Biotech Beach

  Sirenas Receives Research Grant Totaling $1.68 M To Accelerate Its Drug Discovery Technology, ATLANTIS™

  Sirenas announced that it has received a new grant from the Bill & Melinda Gates Foundation to advance ATLANTIS.

  December 13, 2017

   · 

  3 min read
• Business

  Audentes Therapeutics Appoints Mark A. Goldberg, M.D. to its Board of Directors

  Dr. Goldberg is a rare disease leader who brings over 20 years of experience developing and commercializing products to address serious unmet medical needs.

  December 13, 2017

   · 

  4 min read
• Business

  X-Chem and Abilita Bio Announce a Joint Research Collaboration

  Under the terms of the agreement, Abilita will generate EMPs for several high-value GPCR and ion-channel targets, which will be screened by X-Chem using its proprietary DEX libraries to identify agonists and/or antagonists, as dictated by the target biology and desired mechanism of action.

  December 13, 2017

   · 

  5 min read
• Business

  Accelerator Corporation Announces Key Senior Leadership Appointments and Name Change to Accelerator Life Science Partners

  Accelerator Corporation today announced the appointments of Kendall Mohler, Ph.D., to the newly created position of chief development officer, and Ian Howes to chief financial officer.

  December 13, 2017

   · 

  4 min read
• Deals

  Millar Announces the Sale of Life Sciences Telemetry Product Line to Kaha Sciences

  The transition of this product line from Millar will be complete by Dec. 31, 2017

  December 13, 2017

   · 

  2 min read
• Pharm Country

  Regeneron Collaboration Programs Highlighted During Sanofi Analyst Day

  In a separate release today the companies also shared positive topline results for PD-1 antibody cemiplimab in advanced CSCC.

  December 13, 2017

   · 

  8 min read
• Business

  BioLife Solutions Executes Supply Agreement with Iovance Biotherapeutics

  BioLife Solutions today announced that it has executed an agreement to supply its CryoStor cell freeze media and HypoThermosol cell storage and shipping media to Iovance Biotherapeutics.

  December 13, 2017

   · 

  6 min read
• Business

  Lilly Announces 2018 Financial Guidance and Enhances Outlook Through 2020

  Eli Lilly today announced its 2018 financial guidance, including low-single-digit revenue growth driven by volume from recently launched pharmaceutical products.

  December 13, 2017

   · 

  10 min read
• Genetown

  Concert Pharmaceuticals to Be Added to NASDAQ Biotechnology Index

  Concert Pharma announced that it has been selected for addition to the NASDAQ Biotechnology Index effective prior to the market open on Monday, December 18, 2017.

  December 13, 2017

   · 

  1 min read